These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20446571)

  • 1. [The clinical significance of early intervention for impaired glucose tolerance].
    Kawanami D; Utsunomiya K
    Nihon Rinsho; 2010 May; 68(5):797-802. PubMed ID: 20446571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus.
    Delorme S; Chiasson JL
    Curr Opin Pharmacol; 2005 Apr; 5(2):184-9. PubMed ID: 15780829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
    Milicevic Z; Raz I; Beattie SD; Campaigne BN; Sarwat S; Gromniak E; Kowalska I; Galic E; Tan M; Hanefeld M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S155-60. PubMed ID: 18227478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of tissue damage in the postprandial state.
    Ceriello A
    Int J Clin Pract Suppl; 2001 Sep; (123):7-12. PubMed ID: 11594300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.
    Roman G; Hancu N
    Horm Metab Res; 2009 Feb; 41(2):116-22. PubMed ID: 19214921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucose intolerance: postprandial hyper glucose, risk factor for diabetic macroangiopathy].
    Igarashi Y; Kawamori R
    Nihon Rinsho; 2006 Nov; 64(11):1998-2004. PubMed ID: 17087289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postprandial hyperglycemia and diabetic complications].
    Da Ros R; Assaloni R; Ceriello A
    Recenti Prog Med; 2005 Sep; 96(9):436-44. PubMed ID: 16229326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postprandial hyperglycemia as a risk factor in the development of endothelial dysfunction--how to prevent?].
    Ljubić S; Boras J; Vidjak V
    Lijec Vjesn; 2008; 130(1-2):21-5. PubMed ID: 18589639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediabetes: to treat or not to treat?
    Moutzouri E; Tsimihodimos V; Rizos E; Elisaf M
    Eur J Pharmacol; 2011 Dec; 672(1-3):9-19. PubMed ID: 22020287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediabetes: the importance of early identification and intervention.
    Hsueh WA; Orloski L; Wyne K
    Postgrad Med; 2010 Jul; 122(4):129-43. PubMed ID: 20675976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.
    Sanusi H
    Acta Med Indones; 2004; 36(1):36-41. PubMed ID: 15673935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes.
    Su Y; Liu XM; Sun YM; Jin HB; Fu R; Wang YY; Wu Y; Luan Y
    Int J Clin Pract; 2008 Jun; 62(6):877-82. PubMed ID: 18479281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance.
    Xiang GD; Sun HL; Zhao LS; Hou J; Yue L; Xu L
    Clin Endocrinol (Oxf); 2008 May; 68(5):716-23. PubMed ID: 18070144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inadequacies of absolute threshold levels for diagnosing prediabetes.
    Bergman M
    Diabetes Metab Res Rev; 2010 Jan; 26(1):3-6. PubMed ID: 20101658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postprandial hyperglycemia as a risk factor for cardiovascular disease. Therapy improves prognosis].
    Hanefeld M; Schaper F
    Herz; 2004 Aug; 29(5):480-7. PubMed ID: 15340733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry.
    Ziegler D; Rathmann W; Meisinger C; Dickhaus T; Mielck A;
    Eur J Pain; 2009 Jul; 13(6):582-7. PubMed ID: 18782673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.